Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 602 05 891.0 |
96 | EP file number | EAKZ | 02 75 0526.2 |
86 | WO file number | WAKZ | PCT/EP02/01832 |
97 | EP publication number | EPN | 1392714 |
87 | WO publication number | WPN | 2002072598 |
54 | Designation/title | TI | STEROIDE ALS AGONISTEN FÜR FXR |
51 | IPC main class | ICM (ICMV) | C07J 9/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/575 (2006.01), A61P 9/10 (2006.01) |
22 | DE application date | DAT | Feb 21, 2002 |
96 | EP application date | EAT | Feb 21, 2002 |
86 | WO application date | WAT | Feb 21, 2002 |
43 | Date of first publication | OT | Sep 19, 2002 |
| Date of publication of grant | PET | Aug 31, 2005 |
71/73 | Applicant/owner | INH | Intercept Pharmaceuticals, Inc., New York, NY, US |
72 | Inventor | IN | Pellicciari, Roberto, 06100 Perugia, IT |
74 | Representative | VTR | GILLE HRABAL Partnerschaftsgesellschaft mbB Patentanwälte, 40593 Düsseldorf, DE |
10 | Published DE documents | DEPN | Original document:
DE000060205891T2 Searchable text:
DE000060205891T2 |
| Address for service | | GILLE HRABAL Partnerschaftsgesellschaft mbB Patentanwälte, 40593 Düsseldorf, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 274959 P Mar 12, 2001
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2017 000 034.2 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001392714 Searchable text:
EP000001392714 Original document:
EP000001392714B1 Searchable text:
EP000001392714B1 Original document:
WO002002072598 Searchable text:
WO002002072598 |
43 | Date of first publication | EVT | Sep 19, 2002 |
| Date of the first transfer into DPMAregister | EREGT | Sep 30, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 27, 2023 (Show all update days)(Hide all update days)- Jul 27, 2023; Jun 17, 2023; Jun 15, 2023; Feb 23, 2022; Apr 20, 2021; Mar 5, 2021; Mar 12, 2020; Aug 13, 2019; Mar 13, 2019; Mar 9, 2019; Oct 29, 2018; Mar 8, 2018; Jun 13, 2017; May 24, 2017; Mar 9, 2017; Mar 11, 2016; Feb 26, 2015; Mar 18, 2014; Mar 11, 2014; Mar 16, 2013; Mar 12, 2013; Jan 26, 2013
- Historical data not available for this/these date(s)
- Sep 30, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 28, 2005 |
71/73 | Applicant/owner | INH | Intercept Pharmaceuticals, Inc., New York, NY, US |
71/73 | Previous applicant/owner | INHF | Pellicciari, Roberto, Perugia, IT |
| Date of update of the procedure | REGT | Apr 20, 2021 |